BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 19218279)

  • 1. New therapeutic advances in the management of progressive thyroid cancer.
    Woyach JA; Shah MH
    Endocr Relat Cancer; 2009 Sep; 16(3):715-31. PubMed ID: 19218279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and therapy of thyroid cancer in childhood and adolescence.
    Bucsky P; Parlowsky T
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():70-3. PubMed ID: 9439921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New molecular targeted therapies in thyroid cancer.
    Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
    Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.
    Kojic KL; Kojic SL; Wiseman SM
    Expert Rev Anticancer Ther; 2012 Mar; 12(3):345-57. PubMed ID: 22369326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid cancer: therapeutic targets and molecular markers.
    Ball DW
    Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular nuclear therapies for thyroid carcinoma.
    Verburg FA; Brans B; Mottaghy FM
    Methods; 2011 Nov; 55(3):230-7. PubMed ID: 21704168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
    Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
    Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
    Messina M; Robinson BG
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary, anaplastic, and metastatic cancers of the thyroid.
    Pitt SC; Moley JF
    Semin Oncol; 2010 Dec; 37(6):567-79. PubMed ID: 21167376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research.
    Sarlis NJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):103-15. PubMed ID: 12476792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cancer in young adults.
    Ying AK; Huh W; Bottomley S; Evans DB; Waguespack SG
    Semin Oncol; 2009 Jun; 36(3):258-74. PubMed ID: 19460583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New trends in the clinicopathological features of differentiated thyroid cancer in Central Jordan.
    Shomaf MS; Younes NA; Albsoul NM; Musmar AA; Al-Zaheri MM; Tarawneh MS; Sroujieh AS
    Saudi Med J; 2006 Feb; 27(2):185-90. PubMed ID: 16501673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precedents of benign thyroid pathology in carcinoma of the thyroid].
    Abeatici S; Palestini N; Durando R; Fortunato A
    Chir Ital; 1994; 46(4):75-7. PubMed ID: 7882450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic thyroid cancer: a comprehensive review of novel therapy.
    Kojic SL; Strugnell SS; Wiseman SM
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):387-402. PubMed ID: 21417853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid malignancies: a New Zealand South Island thyroid clinic experience 1995-2006.
    Brownlie B; Mercer P; Turner J; Allison R
    N Z Med J; 2008 Aug; 121(1279):36-45. PubMed ID: 18709046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy in radioiodine refractory thyroid cancer.
    Pacini F; Brilli L; Marchisotta S
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anaplastic carcinoma of the thyroid: diagnosis and treatment].
    Giuffrida D; Lavenia G; Aiello RA; Di Blasi C; Gambera G; Pappalardo A; Petralia G; Ursino M; Failla G
    Clin Ter; 2001; 152(4):255-61. PubMed ID: 11725619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
    Cerrato A; De Falco V; Santoro M
    J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.